

The Pharm So Hard Emergency Medicine & Hospital Pharmacy Podcast
Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP
The Pharm So Hard Podcast is a show focused primarily on emergency medicine and hospital pharmacy related topics. Episodes range from 5-30 minutes depending on the topic and guest speakers. The goal is to disseminate information in bite-sized episodes from experts in the field of acute care and hospital pharmacy sub-specialties.
Episodes
Mentioned books

Feb 10, 2026 • 41min
Episode 129. JACP Spotlight: Reducing Prescription Abandonment With ED Pharmacy Kiosks
In Episode 129 of The Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, is joined by Oscar Santalo, PharmD, MBA, MHA, BCPS, to discuss his recently published study in the Journal of Acute Care Pharmacotherapy (JACP) examining prescription abandonment after emergency department discharge. Jimmy and Oscar walk through the motivation behind the research and explore how automated pharmacy kiosks may serve as a practical solution to improve medication access at the point of discharge. The conversation focuses on why prescription abandonment remains a persistent challenge in emergency care and how pharmacy-led innovations can help bridge gaps during transitions from the ED to home. This episode also takes a broader look at the role of clinical pharmacy in emergency medicine, highlighting how system-level approaches can support adherence, continuity of care, and better patient experiences. If you’re interested in how evidence published in JACP can inform real-world practice, this episode offers thoughtful insight from the study’s author himself.
★ Support this podcast ★

Jan 28, 2026 • 20min
Episode 128. Don't Ask Why Give it in the Thigh!! IM Epinephrine in Anaphylaxis
They tackle why intramuscular epinephrine in the deltoid often fails and how thigh injections produce much higher plasma levels. They review pharmacokinetic data, absorption physiology, and needle length problems. They debate weight-based versus fixed dosing and argue for larger IM doses in adults to avoid risky IV boluses.

Jan 15, 2026 • 29min
Episode 127. RSI Trial: Ketamine vs Etomidate
In Episode 127 of The Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, breaks down the long-awaited RSI Trial comparing ketamine versus etomidate for rapid sequence intubation in critically ill patients. Challenging more than two decades of dogma, Jimmy explores why ketamine was associated with more early cardiovascular collapse—including higher rates of vasopressor escalation and significant blood pressure drops—despite its reputation as the “safer” agent in shock. Using real-world scenarios from the ED and ICU, this episode unpacks the concept of the ketamine hemodynamic paradox, catecholamine depletion, dosing considerations, and how these findings should change your airway preparation strategy. If you care about making intubations as boring—and as safe—as possible, this is a must-listen.
★ Support this podcast ★

11 snips
Oct 10, 2025 • 50min
Episode 126. Part 2 – Loop There It Is! Navigating Diuretics, Resistance, and Heart Failure Therapies
Dr. Cait Kulig, a cardiology clinician-educator specializing in heart failure management, returns to delve into diuretics and resistance strategies. She highlights the adverse effects of diuresis, including electrolyte imbalances and ototoxicity. Cait discusses innovative solutions like SGLT2s and inotropes, comparing critical options like milrinone and dobutamine. She emphasizes the importance of guideline-directed therapy for HFrEF and HFpEF and shares tips for optimizing treatment during inpatient care, ensuring safe and effective diuresis throughout.

5 snips
Oct 10, 2025 • 35min
Episode 125. Part 1 – Loop There It Is! Mastering the Foundations of Heart Failure
Cait E. Kulig, a skilled clinical cardiology pharmacist and educator specializing in heart failure, joins host Jimmy Pruitt for an enlightening discussion. They unpack the complexities of heart failure, explaining ejection fraction and the Forrester plot in relatable terms. Cait shares key insights on distinguishing between systolic and diastolic heart failure and the importance of hospitalization in prognosis. Listeners learn practical questions to ask patients and strategies for managing guideline-directed medical therapy effectively.

May 13, 2025 • 7min
Episode 124. Minor Hemorrhages, Major Questions: To Reverse or Not to Reverse in Minor TICH
The podcast dives into the intriguing debate over anticoagulation reversal for minor traumatic intracranial hemorrhages. It highlights a recent study that challenges existing guidelines, urging personalized approaches over one-size-fits-all solutions. Listeners will discover the complexities of clinical judgment in these cases and the potential impact on future treatment strategies. This nuanced discussion could change how emergency departments handle such delicate scenarios.

Apr 4, 2025 • 28min
Episode 123. Unveiling SEMP: A New Era in Emergency Medicine Pharmacy
In this episode of The Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP, introduces the Society of Emergency Medicine Pharmacists (SEMP), a newly established organization dedicated to advancing the practice of emergency medicine pharmacy. Jimmy discusses SEMP's mission to optimize pharmacotherapeutic care in emergency departments through practice improvement, education, advocacy, research, and international collaboration. He highlights the importance of creating a unified global community for emergency medicine pharmacists and explores how SEMP aims to provide tailored support and resources for practitioners in this dynamic field. Tune in to learn how SEMP plans to shape the future of emergency medicine pharmacy and how you can get involved.
★ Support this podcast ★

9 snips
Feb 26, 2025 • 27min
Episode 122. SGLT2 Inhibitors in the ICU - Are We Missing an Opportunity?
Daniella Abi Kheir, a critical care pharmacy resident and SGLT2 inhibitor expert, joins host Jimmy Pruitt to explore the revolutionary potential of these drugs in ICU settings. They discuss the DEFENDER trial, unveiling how SGLT2 inhibitors may prevent renal replacement therapy and enhance outcomes in sepsis. The duo addresses safety concerns, such as DKA, and emphasizes the need for healthcare professionals to rethink these agents' roles. Additionally, they highlight the multifaceted benefits of SGLT2 inhibitors beyond diabetes management.

Feb 5, 2025 • 11min
Episode 121. Journavix: A New Era in Non-Opioid Pain Management?
A groundbreaking non-opioid pain medication, Journavix, is celebrated as the first of its kind in over 20 years. Experts discuss its unique sodium channel blocking mechanism and analyze clinical trial data showcasing its efficacy and safety. They delve into potential side effects and drug interactions, emphasizing its significance for pain management in emergency settings. The conversation also highlights cost implications, accessibility challenges, and the medication's potential to mitigate addiction risks while providing effective pain relief.

Jan 29, 2025 • 11min
Episode 120. Ketamine for Benzodiazepine-Resistant Status Epilepticus – A Game-Changer?
Explore the groundbreaking use of ketamine as a rescue medication for benzodiazepine-resistant status epilepticus. This research highlights its rapid ability to terminate seizures, potentially revolutionizing emergency management protocols. Insightful discussions include safety, dosing, and practical applications in the emergency department. The episode underscores the importance of considering specific patient populations and the need for further research. Plus, there's excitement about an upcoming medical conference to expand on these findings.


